Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company ’s Digital Pathology Business

Company to expand robust Enterprise Imaging offering with addition of Inspirata’s Digital Pathology technology and team FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspirata’s Dynamyx® digital pathology technology, employees and customers will become part of Fujifilm. The addition of digital pathology will expand Fujifilm’s robust Synapse® Enterprise Imaging offering to enable the integration of pathology images and data into a healthcare organization’s electronic health record system and help to streamline care delivery for oncology patients and provider teams. Building off the success of its established partnership with Inspirata, this acquisition marks Fujifilm’s full-scale, global entry into the largely unpenetrated digital pathology market, where 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog. “Acquiring Inspirata’s digital pathology business allows Fujifilm to be an even stronger healthcare partner – bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise,” says Teiichi Goto, president and CEO, representative director at FUJIFILM Corporation. “We’re thrilled to...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Cardiology PACS digital pathology Dynamyx FUJIFILM FUJIFILM Corporation FUJIFILM Healthcare Americas Corporation FUJIFILM Healthcare Europe FUJIFILM Medical Systems Europe Fujifilm’s Robust Synapse® E Source Type: blogs